406 related articles for article (PubMed ID: 2984282)
1. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
Tosato G; Straus S; Henle W; Pike SE; Blaese RM
J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
[TBL] [Abstract][Full Text] [Related]
2. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.
Tosato G; Magrath I; Koski I; Dooley N; Blaese M
N Engl J Med; 1979 Nov; 301(21):1133-7. PubMed ID: 226884
[TBL] [Abstract][Full Text] [Related]
3. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
Tosato G; Magrath IT; Blaese RM
J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
Wingate PJ; McAulay KA; Anthony IC; Crawford DH
J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
[TBL] [Abstract][Full Text] [Related]
5. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.
Wang F; Blaese RM; Zoon KC; Tosato G
J Clin Invest; 1987 Jan; 79(1):7-14. PubMed ID: 3025263
[TBL] [Abstract][Full Text] [Related]
6. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
[TBL] [Abstract][Full Text] [Related]
8. CD8 lymphocytes during Epstein Barr virus (EBV) infection: A CD29 positive population is expanded in acute infectious mononucleosis.
de Paoli P; Gennari D; Reitano M; Martelli P; Sacilotto C; Comoretto R; Santini G
Allergol Immunopathol (Madr); 1991; 19(2):95-7. PubMed ID: 1722959
[TBL] [Abstract][Full Text] [Related]
9. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
Thorley-Lawson DA
J Immunol; 1980 Feb; 124(2):745-51. PubMed ID: 6243331
[TBL] [Abstract][Full Text] [Related]
10. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
Al Tabaa Y; Tuaillon E; Jeziorski E; Ouedraogo DE; Bolloré K; Rubbo PA; Foulongne V; Rodière M; Vendrell JP
J Clin Virol; 2011 Sep; 52(1):33-7. PubMed ID: 21684200
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
Royston I; Sullivan JL; Periman PO; Perlin E
N Engl J Med; 1975 Dec; 293(23):1159-63. PubMed ID: 171568
[TBL] [Abstract][Full Text] [Related]
12. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
Klein E; Ernberg I; Masucci MG; Szigeti R; Wu YT; Masucci G; Svedmyr E
Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
Tsokos GC; Magrath IT; Balow JE
J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
[TBL] [Abstract][Full Text] [Related]
14. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series.
Fark AR
J Fam Pract; 1991 Feb; 32(2):202, 205-6, 209. PubMed ID: 1846641
[TBL] [Abstract][Full Text] [Related]
15. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
Wasik M; Myc A; Matej H; Rudzka L
Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
[TBL] [Abstract][Full Text] [Related]
16. Immunoregulatory functions of cultured human T lymphocytes.
Uchiyama T; Broder S; Bonnard GD; Waldmann TA
Trans Assoc Am Physicians; 1980; 93():251-62. PubMed ID: 6264658
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
18. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis].
Imai S
Hokkaido Igaku Zasshi; 1990 Sep; 65(5):481-92. PubMed ID: 2172132
[TBL] [Abstract][Full Text] [Related]
19. Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV).
Gergely P; Ernberg I; Klein G; Steinitz M
Clin Exp Immunol; 1977 Dec; 30(3):347-53. PubMed ID: 203426
[TBL] [Abstract][Full Text] [Related]
20. CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission.
Marshall NA; Culligan DJ; Johnston PW; Millar C; Barker RN; Vickers MA
Br J Haematol; 2007 Oct; 139(1):81-9. PubMed ID: 17854310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
